Approval of a novel antibody-drug conjugate ushers in new second-line option.
Smoking increases exposure to carbon monoxide, and this may be associated with better clinical response to autophagy inhibitors.
When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.
Continuous innovation is required in various technological aspects to effectively manage the challenges of vast clinical data.
Novel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.
Pandemic allows technicians to shine and be increasingly viewed as key to streamlining workflow.
Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Community pharmacy leaders should focus on improving quality of work-life for their employees.
Studies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
This article is sponsored by Azurity Pharmaceuticals, Inc.
Explore the definition of digiceuticals, current digiceutical products available, and pharmacy implications.
Digitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.
Failing is not final, and it does not define what kind of pharmacist or resident a student can be.
Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Migraine is a chronic neurological disease characterized by throbbing or pulsating unilateral or bilateral headache that can last from hours to days.
Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.
Meaningful reform was challenging in 2024, but this year could turn the tide.
Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.
Closing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.
Beyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.
A projected shortage of trained staff in the years ahead demands looking beyond normal hiring channels.
Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
Experts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.
Although approximately 95% of online drug sellers operate illegally, many consumers may never know the medications they receive are not what they claim to be.
As use of injectable medications increases for diabetes and other indications, proper administration is crucial.
There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Lack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.